Latest Financial Health News

Opthea Limited faces a pivotal moment as four board members resign following disappointing Phase 3 trial results and a major workforce reduction. The company’s future hinges on ongoing funding negotiations amid trading suspensions.

Toys"R"Us ANZ Limited reported a significant increase in product margins and sales revenue despite inventory challenges, while advancing a recapitalisation plan to secure its financial future.

QEM Limited's trading suspension has been lifted immediately following its announcement of a new capital raise, signaling a pivotal moment for the company’s financial strategy.

Aroa Biosurgery has reported FY25 results that exceed revenue guidance and deliver a positive normalised EBITDA, setting the stage for ambitious growth and reimbursement expansion in FY26.

RPMGlobal Holdings has announced a 12-month extension to its on-market share buy-back program, adding up to 11 million shares to be repurchased. This move underscores the company’s confidence in its valuation and capital management strategy.

Experience Co Limited has announced a significant on-market share buy-back of up to 10% of its issued capital, signaling renewed confidence in its financial health and future prospects.

Viva Leisure has taken a strategic 33% stake in Gorilla X Labs, aiming to deepen its footprint in the sports nutrition market and enhance member offerings across its platforms.

Noble Helium has secured significant cost savings by negotiating the removal of the Marriott rig from Tanzania at no economic risk, while preparing a leaner drilling approach with the BorExpert rig.

3P Learning forecasts steady revenue for FY25 but anticipates a significant 20% uplift in underlying EBITDA and a stronger net cash position, driven by strategic product expansions.

Lucapa Diamond Company and its subsidiaries have appointed voluntary administrators as they embark on a dual-track recapitalisation and sale process to address financial distress.

Bendigo and Adelaide Bank reported a slight dip in its Common Equity Tier 1 ratio to 10.83% for the March 2025 quarter, reflecting dividend payments and increased residential lending. Despite this, the bank sustained robust liquidity and funding metrics well above regulatory minimums.

SKS Technologies has delivered a robust first half in 2025, showcasing strong revenue growth and a burgeoning project pipeline, underpinned by zero debt and strategic expansion in data centres and traditional electrical services.